On March 8, 2018, Geisinger, a health system and health plan in Central Pennsylvania, announced plans to expand its ProvenCare Total Hip program with Medacta International, via a pilot that will cover consumers’ lifetime costs of any subsequent hip replacement surgery. Medacta International is the hip replacement device vendor. For the pilot, Geisinger Health Plan members who undergo hip replacement surgery will be eligible to receive future surgical revisions at no charge when all services are delivered to Geisinger Health Plan members by Geisinger provider organizations. These costs will be proportionally shared between Geisinger and Medacta, including the device itself . . .